U.S. FDA grants priority review to Pfizer's RSV vaccine




  • In US
  • 2022-12-07 11:52:49Z
  • By Reuters
 

(Reuters) -Pfizer Inc said on Wednesday the U.S. Food and Drug Administration will review its respiratory syncytial virus (RSV) vaccine candidate on priority.

The drugmaker is seeking approval for use of the vaccine, RSVpreF, in adults aged 60 years and older and the agency is set to make its decision by May 2023. It could become the first approved RSV vaccine in the U.S. for older adults who are at risk of the lung disease.

Pfizer's application to the FDA is supported by data from a late-stage study in which the vaccine was found safe and effective.

The vaccine was 85.7% effective among participants with three or more symptoms, and 66.7% for two or more symptoms, according to an interim analysis carried out by an external data monitoring panel.

There are no U.S. approved vaccines for RSV, a common virus that typically causes mild cold-like symptoms but can be fatal for young kids and older adults. RSV is estimated to cause about 14,000 annual deaths among older adults in the United States.

(Reporting by Bhanvi Satija and Khushi Mandowara in Bengaluru; Editing by Krishna Chandra Eluri)

COMMENTS

More Related News

U.S. FDA calls for new regulatory framework for use of cannabis compound CBD
U.S. FDA calls for new regulatory framework for use of cannabis compound CBD
  • US
  • 2023-01-26 18:37:36Z

The health regulator said it would work with Congress to develop a new, cross-agency regulatory framework. The FDA denied three citizen petitions that had...

U.S. CDC still looking at potential stroke risk from Pfizer bivalent COVID shot
U.S. CDC still looking at potential stroke risk from Pfizer bivalent COVID shot
  • US
  • 2023-01-26 18:25:41Z

New data from one U.S. Centers for Disease Control and Prevention (CDC) database shows a possible stroke risk link for older adults who received an updated...

FDA identifies recall of Emergent
FDA identifies recall of Emergent's decontamination kits as most serious
  • US
  • 2023-01-26 15:28:58Z

The contract manufacturer began the recall of 3500 units of the kit in November, after receiving three customer complaints of leakage from the packets...

FDA vaccine panel to consider recommending annual COVID shots: What we know
FDA vaccine panel to consider recommending annual COVID shots: What we know

The Vaccines and Related Biological Products Advisory Committee meets Thursday to consider how to update guidelines for COVID-19 booster shots.

Those UV lamps nail salons use? Researchers say they can permanently change your DNA
Those UV lamps nail salons use? Researchers say they can permanently change your DNA

The team exposed human and mouse cells to UV rays and found that radiation emitted by UV-nail polish dryers can permanently damage DNA.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US